Breaking News

Argenta Global Receives NZ R&D Grant

Grant reimburses 20% of eligible R&D expenses

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

The New Zealand Ministry of Science has approved Argenta Global for a $4.7 million Technology Development Grant. The grant reimburses 20% of eligible R&D expenses, as much as $2.4 million per year. “Argenta R&D transforms animal health innovations into commercially viable products,” said Doug Cleverly, Argenta founder and chief executive officer.  “We also manufacture and ship those products to more than 40 countries on behalf of our customers. The Technology Development Grant helps ens...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters